Eli Lilly (LLY) Gets FDA Nod for Alzheimer’s Drug Donanemab
ZacksEli Lilly’s (LLY) Alzheimer’s disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the disease.
Eli Lilly’s (LLY) Alzheimer’s disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the disease.
